1. Hazlina NH, Norhayati MN, Bahari IS, Arif NA. Worldwide prevalence, risk factors and psychological impact of infertility among women: a systematic review and meta-analysis. BMJ open 2022; 12(3):e057132.
2. Tavousi SA, Behjati M, Milajerdi A, Mohammadi AH. Psychological assessment in infertility: A systematic review and meta-analysis. Frontiers in Psychology 2022; 13:961722.
3. Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. The lancet Diabetes & endocrinology 2022; 10(9):668-80.
4. Hasan M, Sultana S, Sohan M, Parvin S, Rahman MA, Hossain MJ, et al. Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross—Sectional study. PloS one 2022; 17(6):e0270102.
5. Li G, Jiang Z, Kang X, Ma L, Han X, Fang M. Trajectories and predictors of anxiety and depression amongst infertile women during their first IVF/ICSI treatment cycle. Journal of Psychosomatic Research 2021; 142:110357.
6. Abulizi M, Xu H, Abuduguli A, Zhao W, He L, Zhang C. Dual mediating effects of social support and fertility stress on mindfulness and fertility quality of life in infertile men: a case-control study. Frontiers in Psychology 2023; 14:1138282.
7. Roozitalab S, Rahimzadeh M, Mirmajidi SR, Ataee M, Saeieh SE. The relationship between infertility, stress, and quality of life with posttraumatic stress disorder in infertile women. Journal of Reproduction & Infertility 2021; 22(4):282.
8. Iordachescu DA, Gica C, Vladislav EO, Panaitescu AM, Peltecu G, Furtuna ME, et al. Emotional disorders, marital adaptation and the moderating role of social support for couples under treatment for infertility. Ginekologia polska 2021; 92(2):98-104.
9. Manique ME, Ferreira AM. Polycystic ovary syndrome in adolescence: challenges in diagnosis and management. Revista brasileira de ginecologia e obstetricia 2022; 44(04):425-33.
10. Helvaci N, Yildiz BO. Polycystic ovary syndrome as a metabolic disease. Nature Reviews Endocrinology 2025; 21(4):230-44.
11. Stańczak NA, Grywalska E, Dudzińska E. The latest reports and treatment methods on polycystic ovary syndrome. Annals of medicine 2024; 56(1):2357737.
12. Collée J, Mawet M, Tebache L, Nisolle M, Brichant G. Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecological Endocrinology 2021; 37(10):869-74.
13. Islam H, Masud J, Islam YN, Haque FK. An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Women's Health 2022; 18:17455057221117966.
14. Vazquez-Levin MH, Verón GL. Myo‐inositol in health and disease: its impact on semen parameters and male fertility. Andrology 2020; 8(2):277-98.
15. Etrusco A, Laganà AS, Chiantera V, Buzzaccarini G, Unfer V. Myo-inositol in assisted reproductive technology from bench to bedside. Trends in Endocrinology & Metabolism 2024; 35(1):74-83.
16. Pivazyan L, Krylova E, Obosyan L, Seregina V, Shapovalenko R, Ayryan E. Effectiveness of Myo-Inositol on Oocyte and Embryo Quality in Assisted Reproduction: Systematic Review and Meta-Analysis of Randomized Clinical Trials. Gynecologic and Obstetric Investigation 2025; 90(1):78-92.
17. Formuso C, Stracquadanio M, Ciotta L. Myo-inositol vs. D-chiro inositol in PCOS treatment. Minerva Ginecol 2015; 67(4):321-5.
18. Rani C, Deeba F, Ishrat S, Banu J, Jahan S, Nazneen S, et al. Effects of metformin plus myo-inositol compared to metformin alone as pre-treatment of ovulation induction in polycystic ovary syndrome with insulin resistance. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2022; 11(11):3006.
19. Wdowiak A, Filip M. The effect of myo-inositol, vitamin D3 and melatonin on the oocyte quality and pregnancy in in vitro fertilization: a randomized prospective controlled trial. European Review for Medical & Pharmacological Sciences 2020; 24(16).
20. Nazari L, Salehpour S, Hosseini S, Saharkhiz N, Azizi E, Hashemi T, et al. Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial. Journal of gynecology obstetrics and human reproduction 2020; 49(5):101698.
21. Mohammadi S, Eini F, Bazarganipour F, Taghavi SA, Kutenaee MA. The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial. Reproductive biology and endocrinology 2021; 19(1):61.
22. Caprio F, D’Eufemia MD, Trotta C, Campitiello MR, Ianniello R, Mele D, et al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. Journal of ovarian research 2015; 8(1):37.